Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Multi-tissue RNA-seq and transcriptome characterisation of the spiny dogfish shark (Squalus acanthias) provides a molecular tool for biological research and reveals new genes involved in osmoregulation.

Chana-Munoz A, Jendroszek A, Sønnichsen M, Kristiansen R, Jensen JK, Andreasen PA, Bendixen C, Panitz F.

PLoS One. 2017 Aug 23;12(8):e0182756. doi: 10.1371/journal.pone.0182756. eCollection 2017.

2.

A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.

Perni M, Galvagnion C, Maltsev A, Meisl G, Müller MB, Challa PK, Kirkegaard JB, Flagmeier P, Cohen SI, Cascella R, Chen SW, Limboker R, Sormanni P, Heller GT, Aprile FA, Cremades N, Cecchi C, Chiti F, Nollen EA, Knowles TP, Vendruscolo M, Bax A, Zasloff M, Dobson CM.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E1009-E1017. doi: 10.1073/pnas.1610586114. Epub 2017 Jan 17. Erratum in: Proc Natl Acad Sci U S A. 2017 Mar 21;114(12 ):E2543.

3.

A network model for angiogenesis in ovarian cancer.

Glass K, Quackenbush J, Spentzos D, Haibe-Kains B, Yuan GC.

BMC Bioinformatics. 2015 Apr 11;16:115. doi: 10.1186/s12859-015-0551-y.

4.

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.

Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF.

Br J Cancer. 2014 Jan 21;110(2):341-52. doi: 10.1038/bjc.2013.752. Epub 2013 Dec 3.

5.

Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.

El-Kenawi AE, El-Remessy AB.

Br J Pharmacol. 2013 Oct;170(4):712-29. doi: 10.1111/bph.12344. Review.

6.

Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties.

de Medina P, Paillasse MR, Segala G, Voisin M, Mhamdi L, Dalenc F, Lacroix-Triki M, Filleron T, Pont F, Saati TA, Morisseau C, Hammock BD, Silvente-Poirot S, Poirot M.

Nat Commun. 2013;4:1840. doi: 10.1038/ncomms2835.

7.

Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer.

Garon EB, Pietras RJ, Finn RS, Kamranpour N, Pitts S, Márquez-Garbán DC, Desai AJ, Dering J, Hosmer W, von Euw EM, Dubinett SM, Slamon DJ.

J Thorac Oncol. 2013 Mar;8(3):270-8. doi: 10.1097/JTO.0b013e31827d525c.

8.

Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.

Zasloff M, Adams AP, Beckerman B, Campbell A, Han Z, Luijten E, Meza I, Julander J, Mishra A, Qu W, Taylor JM, Weaver SC, Wong GC.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15978-83. doi: 10.1073/pnas.1108558108. Epub 2011 Sep 19. Erratum in: Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18186.

9.

Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.

Marquez-Garban DC, Mah V, Alavi M, Maresh EL, Chen HW, Bagryanova L, Horvath S, Chia D, Garon E, Goodglick L, Pietras RJ.

Steroids. 2011 Aug;76(9):910-20. doi: 10.1016/j.steroids.2011.04.015. Epub 2011 May 8.

10.

Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma.

Wu YH, Cao JG, Xiang HL, Xia H, Qin Y, Huang AJ, Xiao D, Xu F.

World J Gastroenterol. 2009 Apr 14;15(14):1744-50.

11.

Elasmobranch immune cells as a source of novel tumor cell inhibitors: Implications for public health.

Walsh CJ, Luer CA, Bodine AB, Smith CA, Cox HL, Noyes DR, Maura G.

Integr Comp Biol. 2006 Dec 1;46(6):1072-1081.

12.

Targeting aromatase and estrogen signaling in human non-small cell lung cancer.

Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ.

Ann N Y Acad Sci. 2009 Feb;1155:194-205. doi: 10.1111/j.1749-6632.2009.04116.x.

14.

Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET.

Smith-Jones PM, Solit D, Afroze F, Rosen N, Larson SM.

J Nucl Med. 2006 May;47(5):793-6.

15.

Antiangiogenic Steroids in Human Cancer Therapy.

Pietras RJ, Weinberg OK.

Evid Based Complement Alternat Med. 2005 Mar;2(1):49-57. Epub 2005 Feb 9.

Supplemental Content

Support Center